Neuropeptides in the pathophysiology and treatment of cachexia. - Wikidata - wikimedia - TriplyDB

Neuropeptides in the pathophysiology and treatment of cachexia.

Neuropeptides in the pathophysiology and treatment of cachexia.

http://www.wikidata.org/entity/Q34712204

about

Melanocortin control of energy balance: evidence from rodent models.Agouti-related protein segments outside of the receptor binding core are required for enhanced short- and long-term feeding stimulation The agouti-related peptide binds heparan sulfate through segments critical for its orexigenic effects.Dexmedetomidine ameliorates muscle wasting and attenuates the alteration of hypothalamic neuropeptides and inflammation in endotoxemic rats.Hypothalamic activation is essential for endotoxemia-induced acute muscle wasting.The frailty syndrome: a comprehensive review.Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?Metabolic transceivers: in tune with the central melanocortin system.Insulin ameliorating endotoxaemia-induced muscle wasting is associated with the alteration of hypothalamic neuropeptides and inflammation in rats.The hunger hormone ghrelin in cachexia.Current status and future directions: equine pituitary pars intermedia dysfunction and equine metabolic syndrome.

P2860

Q35103464-2D917943-A813-44AE-95A4-7E2CCCB508A6 Q35783645-FDC1C880-7673-4B59-B782-8077A0B43F55 Q36298889-6CF57B7C-96AC-489B-AAF2-3252CFB46733 Q36328267-CC53AC32-ECD4-4BA2-9A61-609D813A3916 Q37475891-236FF7DF-BF9D-4A2A-B983-7CF19B8A2254 Q37958026-DE83EA5B-69F1-4DCC-9B90-856B9AB9E3E3 Q38024726-02974B51-B36C-48C7-96AA-A45FA181D556 Q38062727-37DC8DF2-81D2-4274-A24C-831348D861B5 Q41745913-658E2E18-6D05-472C-A513-973E37571791 Q45844232-C5BCD641-0473-4572-92F0-CF80530EBAEF Q51330358-6F8BAE51-6EFF-4257-85A3-B402E136DF12

P2860

Neuropeptides in the pathophysiology and treatment of cachexia.

http://www.wikidata.org/entity/Q34712204

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Neuropeptides in the pathophysiology and treatment of cachexia.

@ast

Neuropeptides in the pathophysiology and treatment of cachexia.

@en

Neuropeptides in the pathophysiology and treatment of cachexia.

@nl

type

label

Neuropeptides in the pathophysiology and treatment of cachexia.

@ast

Neuropeptides in the pathophysiology and treatment of cachexia.

@en

Neuropeptides in the pathophysiology and treatment of cachexia.

@nl

prefLabel

Neuropeptides in the pathophysiology and treatment of cachexia.

@ast

Neuropeptides in the pathophysiology and treatment of cachexia.

@en

Neuropeptides in the pathophysiology and treatment of cachexia.

@nl

P1433

Q34712204-BF79A3DC-D14D-43CA-ADCC-13A385A9CD48

P1476

Q34712204-BEA87E54-464A-42D9-89E5-4ACAAAB85138

P2093

Q34712204-91698080-6E7D-474C-9245-77F5A9F40233

Q34712204-B04C5E10-D048-4965-8CF6-88A6647C5D0F

P2860

Q34712204-07878D4A-E49E-43F1-A9D2-D383BBC7C382

Q34712204-07A769B3-7284-4E48-89BB-F7C29985A9DE

Q34712204-0881495E-9DFA-4395-AD0D-E3E35C14373D

Q34712204-0A484C58-F07D-421F-B02B-DDE3480ECBFB

Q34712204-0A6696C9-0792-4CA0-90A8-5DBB3750200A

Q34712204-0CFDB94B-83D7-49F0-A219-1A85DA7361BF

Q34712204-10509BD7-B5D8-4852-B917-CB3772C49137

Q34712204-12519AAC-F8EB-4507-906F-ED699767175A

Q34712204-1323931E-76BD-4557-B019-091DA026D866

Q34712204-13618963-6969-4670-96D9-FB9052ABE8E6

P304

Q34712204-7E580BCC-83CE-4AB0-B1FA-EDBA4664D2D3

P31

Q34712204-5B021BBD-6580-4188-8955-E41D365E593B

P356

Q34712204-CE4242AF-B40D-4E8F-9D7C-11FCC0C92838

P433

Q34712204-70288369-4E41-431F-B53D-B1150DCB6A25

P478

Q34712204-D5C96263-5870-4C86-BE10-47867609CA07

P577

Q34712204-263C3C71-2261-4D34-8A1C-A6801282F86C

P5875

Q34712204-F82FC28D-C0EF-4FB3-A35A-00873F17C2E8

P698

Q34712204-ED001EEF-1D4F-4378-BA94-EFE9F55DD362

P921

Q34712204-96D67DF4-7DCF-456F-9736-9D1702C22FED

P932

Q34712204-259CCA89-BCAE-4193-B28F-7EB914A040E2

P356

SPC.0B013E32833E48E7

P1433

Current Opinion in Supportive and Palliative Care

P1476

Neuropeptides in the pathophysiology and treatment of cachexia.

@en

P2093

Daniel L Marks

http://www.w3.org/2001/XMLSchema#string

Stephanie M Krasnow

http://www.w3.org/2001/XMLSchema#string

P2860

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells

Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein

Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models

Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation

A pharmacologically active monoclonal antibody against the human melanocortin-4 receptor: effectiveness after peripheral and central administration

Ghrelin induces adiposity in rodents

Update on melanocortin interventions for cachexia: progress toward clinical application.

Lipopolysaccharide challenge-induced suppression of Fos in hypothalamic orexin neurons: their potential role in sickness behavior

Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile

P304

266-271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/SPC.0B013E32833E48E7

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45821572

http://www.w3.org/2001/XMLSchema#string

P698

20733497

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

3063098

http://www.w3.org/2001/XMLSchema#string